Generally, the first question we hear is, “What plant contains Conolidine?” Conolidine is an alkaloid found in the Tabernaemontana divaricata (Crepe Jasmine) plant. Alkaloids are any naturally occurring organic compounds of plant origin that have strong effects on the brain. Commonly known alkaloids include morphine, ephedrine, and caffeine.
At present, this plant, commonly called Crepe Jasmine is the only known natural source of the Conolidine alkaloid. Believe it or not, Conolidine is not a “new” medicinal herb. Ayurvedic and Chinese traditional medicine has incorporated the Tabernaemontana divaricata plant for centuries.
Recently, developments have been made in synthesizing and concentrating Conolidine for the purpose of studying its effects on pain.
It was not until very recently that the Conolidine alkaloid, obtained from the Crepe Jasmine shrub, started being evaluated for alternative pain treatment as a pain killer. The current metric for pain treatment is to either treat with potentially harmful synthetic anti-inflammatories.
At high doses with limited effects or with a derivative of the poppy plant which runs the risk of addiction, overdose, and even death in serious cases.
Crepe Jasmine: The Conolidine Plant
Obviously, it would be ideal to discover a treatment, whether it be chemical or otherwise, that reduces the risk of the current Western medicine treatments in use. It would seem that based on current and ongoing studies that Conolidine is one of those options.
Using something natural and readily available such as Tabernaemontana divaricata. It can be used as a preemptive treatment for aches, pains, and even more moderate to severe pain. It would assist in slowing issues such as the Opioid Crisis in the United States while maintaining a functional level of pain relief.
Conolidine, as it’s increasingly becoming understood, could end up being a huge leap forward. for people searching for pain relief along with the medical community at large. Continued research and validation of the Crepe Jasmine or Tabernaemontana divaricata shrub should very much be promoted as we learn more about its analgesic properties; moreover, it should become a focal point to help curb the current ebb and flow of our relationship with opiate-based painkillers.